Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Torley Helen, President and Chief Executive Officer. Insider active across 3 companies, notably Halozyme Therapeutics, INC.. Aggregated, 69 disclosures have been recorded. Breakdown: 0 buy · 13 sells. Total volume traded: €5.6m. History available since 11 May 2021. The latest transaction was filed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Torley Helen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Torley Helen is President and Chief Executive Officer and has filed 55 filings in total. Across the 55 sampled filings, the recorded activity consists of sales of EUR 134508, between 2016-01-04 and 2026-07-09, and the most frequent transaction nature is Levée d'options.